Lexaria Bioscience Corp. (NASDAQ:LEXXW) Sees Significant Increase in Short Interest

Lexaria Bioscience Corp. (NASDAQ:LEXXW) was the recipient of a significant growth in short interest in March. As of March 31st, there was short interest totalling 6,000 shares, a growth of 150.0% from the March 15th total of 2,400 shares. Based on an average trading volume of 10,600 shares, the days-to-cover ratio is presently 0.6 days.

Lexaria Bioscience Trading Up 2.8 %

LEXXW stock traded up $0.01 during trading on Wednesday, hitting $0.37. 10,946 shares of the stock traded hands, compared to its average volume of 12,054. Lexaria Bioscience has a one year low of $0.16 and a one year high of $2.00. The company has a 50 day simple moving average of $0.30 and a 200 day simple moving average of $0.57.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.